Expedited regulatory pathway options and utility: Pandemic to endemic
Feature ArticlesSarah A Robinson, MBioChem • Alison R Carter, PhD • David A Brindley, DPhil, MEng, MBA
Biologics/ biosimilars/ vaccinesEuropeNorth AmericaPharmaceuticalsFeature ArticlesSarah A Robinson, MBioChem • Alison R Carter, PhD • David A Brindley, DPhil, MEng, MBABiologics/ biosimilars/ vaccinesEuropeNorth AmericaPharmaceuticals